Recurrence rate by neovascularization following a modification of long saphenous vein operation in the groin: A prospective randomized duplex-ultrasound controlled study;Rezidivhäufigkeit durch neoangiogenese nach modifizierter krossektomie: Prospektiv-randomisierte, farbduplex-kontrollierte studie

Phlebologie

Volumn 34, Issue 2, 2005, Pages 101-104

  Haas, Eva ^a   Burkhardt, J ^b   Maile, N ^a  

^a Schlossklinik Abtsee GmbH   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Neovaskularisation; Recurrence; Saphenofemoral junction; Varicose veins

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; INGUINAL REGION; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RECURRENT DISEASE; SAPHENOUS VEIN; VARICOSIS; VEIN LIGATION; VEIN SURGERY;

EID: 17644423067     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621409     Document Type: Article

References (29)

1. Benabou JE, Molnar LJ, Cerri GG. Duplex sonographic evaluation of the sapheno-femoral venous junction in patients with recurrent varicose veins after surgical treatment. J Clin Ultrasound 1998; 26: 401-404.
2. Bhatti TS, Whitman B, Harradine K et al. Causes of re-recurrence after polytetrafluoroethylene patch saphenoplasty for recurrent varicose veins. Br J Surg 2000; 87: 1356-60.
3. Bradbury AW, Stonebridge PA, Callam MJ et al. Recurrent varicose veins: assessment of the saphenofemoral junction. Br J Surg 1994; 81: 373-5.
4. Braquet P, Chabrier PE, Clostre F. Functions of the endothelium. Presse Med 1994; 23: 225-7.
5. Cao Y, Linden P, Farnebo J et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998; 95: 14389-94.
6. Chandrasekar TS, Balasubramanian SP. Causes of re-recurrence after polytetrafluoroethylene patch saphenoplasty for recurrent varicose veins. Br J Surg 2001; 88: 469.
7. Creton D. Surgery for recurrent saphenofemoral incompetence using expanded polytetrafluoro-ethylene patch interposition in front of the femoral vein: Long-term outcome in 119 extremities. Phlebology 2002;16:137-41.
8. Darke SG. The morphology of recurrent varicose veins. Eur J Vasc Surg 1992; 6: 512-7.
9. De Maeseneer MG, Giuliani DR, Van Schil PE et al. Can interposition of a silicone implant after sapheno-femoral ligation prevent recurrent varicose veins? Eur J Vasc Endovasc Surg 2002; 24: 445-9.
10. De Maeseneer MG, Van Schil PE, Philippe MM et al. Is recurrence of varicose veins after surgery unavoidable? Acta Chir Belg 1995; 95: 21-6.
11. De Maeseneer MG, Vandenbroeck CP, Van Schil PE. Silicone patch saphenoplasty to prevent repeat recurrence after surgery to treat recurrent saphenofemoral incompetence: long-term follow-up study. J Vasc Surg 2004; 40: 98-105.
12. Fischer R, Chandler JG, De Maeseneer MG et al. The unresolved problem of recurrent saphenofemoral reflux. J Am Coll Surg 2002; 195: 80-94.
13. Fischer R, Kluess H, Frings N et al. Der aktuelle Stand der Magnakrossenrezidivforschung. Phlebologie 2003; 32: 54-9.
14. Frings N, Glowacki P, Nelle A et al. Prospektive Studie zur Verhinderung der Neoangiogenese nach Magna-Krossektomie. Erste Ergebnisse. Zentralbl Chir 2000; 126: 528-30.
15. Frings N, Nelle A, Tran P et al. Reduction of neoreflux after correctly performed ligation of the saphenofemoral junction. A randomized trial. Eur J Vasc Endovasc Surg 2004; 28: 246-52.
16. Frings N, Nelle A, Tran V et al. Unvermeidbares Rezidiv und Neoreflux nach korrekter Vena saphena magna Krossektomie: Neovaskularisation. Phlebologie 2003; 32: 96-100.
17. Frings N, Tran P, Nelle A et al. Freies Endothel des Magna- Krossensturapfes und Neoreflux/Neoangiogenese. Phlebologie 2004; 33: 156-9.
18. Frings N, Tran V, Nelle A et al. Krossenrezidiv der V saphena magna trotz korrekter Krossektomie: Neoangiogenese. Phlebologie 1999; 28: 144-8.
19. Glass GM. Preve veins bei forming a partition to contain neovaskularisationntion of sapheno-femoral and sapheno-popliteal recurrence of varicose. Phlebology 1998; 13: 3-9.
20. Hofer T. Die Perforansvenen bei der Entwicklung der epifaszialen Varikosis. Hautarzt 2004; 55: 367-70.
21. Hofer T. Rezidiwarizen: Progression der Varikosis. Phlebologie 2004; 33: 186-90.
22. Kohler A, Dirsch O, Brunner U. Veno-lymphatic angiodysplasia as the cause of recurrent inguinal varicose veins. Vasa 1997; 26: 52-4.
23. Kostas T, Ioannou CV, Touloupakis E et al. Recurrent varicose veins after surgery: a new appraisal of a common and complex problem in vascular surgery. Eur J Vasc Endovasc Surg 2004; 27: 275-82.
24. Maharaj D, Naraynsingh V, Ramdass M. Causes of re-recurrence after polytetrafluoroethylene patch saphenoplasty for recurrent varicose veins. Br J Surg 2001; 88: 730.
25. Michiels C, Arnould T, Remade J. Hypoxia-induced activation of endothelial cells as a possible cause of venous diseases: hypothesis. Angiology 1993; 44: 639-46.
26. Michiels C, Arnould T, Thibaut-Vercruyssen R et al. Perfused human saphenous veins for the study of the origin of varicose veins: role of the endothelium and of hypoxia. Int Angiol 1997; 16: 134-41.
27. Saharay M, Shields DA, Georgiannos SN et al. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998; 15: 342-9.
28. Stücker M, Netz K, Breuckmann F et al. Histomorphologic classification of recurrent saphenofemoral reflux. J Vasc Surg 2004; 39: 816-22.
29. Van Rij AM, Jones GT, Hill GB et al. Neovascularization and recurrent varicose veins: more histologic and ultrasound evidence. J Vasc Surg 2004; 40: 296-302.